Neurodegenerative disease: the kynurenine pathway--promising new targets and therapies for neurodegenerative disease

Comment

Katy Malpass. Nat Rev Neurol. 2011.

. 2011 Jul 26;7(8):417.

doi: 10.1038/nrneurol.2011.102.

No abstract available

Comment on

The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease.
Campesan S, Green EW, Breda C, Sathyasaikumar KV, Muchowski PJ, Schwarcz R, Kyriacou CP, Giorgini F. Campesan S, et al. Curr Biol. 2011 Jun 7;21(11):961-6. doi: 10.1016/j.cub.2011.04.028. Curr Biol. 2011. PMID: 21636279 Free PMC article.
Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration.
Zwilling D, Huang SY, Sathyasaikumar KV, Notarangelo FM, Guidetti P, Wu HQ, Lee J, Truong J, Andrews-Zwilling Y, Hsieh EW, Louie JY, Wu T, Scearce-Levie K, Patrick C, Adame A, Giorgini F, Moussaoui S, Laue G, Rassoulpour A, Flik G, Huang Y, Muchowski JM, Masliah E, Schwarcz R, Muchowski PJ. Zwilling D, et al. Cell. 2011 Jun 10;145(6):863-74. doi: 10.1016/j.cell.2011.05.020. Cell. 2011. PMID: 21640374 Free PMC article.